What is it about aspirin and Covid-19?

via Bar-Ilan University

via Bar-Ilan University

What is it about aspirin and Covid-19?

New study finds aspirin use for cardiovascular disease may reduce likelihood of infection

Aspirin is an established, safe, and low-cost medication in long-standing common use in prevention and treatment of cardiovascular diseases, and in the past a pain relief and fever reducing medication. The use of aspirin was very popular during the 1918 Spanish Influenza pandemic, several decades before in-vitro confirmation of its activity against RNA viruses.  Studies showed that aspirin, in addition to its well-known anti-inflammatory effects, could modulate the innate and adaptive immune responses helping the human immune system battle some viral infections.

With this information in mind Israeli researchers hypothesized that pre-infection treatment with low-dose aspirin (75mg) use might have a potential beneficial effect on COVID-19 susceptibility and disease duration. A joint team from Leumit Health Services, Bar-Ilan University, and Barzilai Medical Center conducted an observational epidemiological study, utilizing data from Leumit Health Services, a national health maintenance organization in Israel.  Their findings were recently published in The FEBS Journal.

The researchers analyzed data of 10,477 persons who had been tested for COVID-19 during the first COVID-19 wave in Israel from February 1, 2020 to June 30, 2020. Aspirin use to avoid the development of cardiovascular diseases in healthy individuals was associated with a 29% lower likelihood of COVID-19 infection, as compared to aspirin non-users. The proportion of patients treated with aspirin was significantly lower among the COVID-19-positive individuals, as compared to the COVID-19-negative ones. And those subjects who had been treated with aspirin were less associated with the likelihood of COVID-19 infection than those who were not. Moreover, the group observed that the conversion time of SARS-CoV-2 PCR test results from positive to negative among aspirin-using COVID-positive patients was significantly shorter, and the disease duration was two-three days shorter, depending upon the patients’ pre-existing conditions.

“This observation of the possible beneficial effect of low doses of aspirin on COVID-19 infection is preliminary but seems very promising,” says Prof. Eli Magen from the Barzilai Medical Center, who led the study.

 

Original Article: Aspirin and COVID-19

More from: Bar-Ilan University

 

See Also

 

The Latest Updates from Bing News & Google News

Go deeper with Bing News on:
Aspirin and Covid-19
Go deeper with Google Headlines on:
Aspirin and Covid-19

[google_news title=”” keyword=”aspirin and Covid-19″ num_posts=”5″ blurb_length=”0″ show_thumb=”left”]

Go deeper with Bing News on:
Effect of low doses of aspirin on COVID-19 infection
Go deeper with Google Headlines on:
Effect of low doses of aspirin on COVID-19 infection

[google_news title=”” keyword=”effect of low doses of aspirin on COVID-19 infection” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]

 

Our Youtube Discovery Picks

[embedyt] https://www.youtube.com/embed?listType=playlist&list=PL0UjJ07OSXC83oV409r1yRju8-ihA1InJ&layout=gallery[/embedyt]

 

 

What's Your Reaction?
Don't Like it!
0
I Like it!
0
Scroll To Top